Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate

Plus, news about Nuvation Bio, Leqembi, IN8bio and Syros: Longtime clot-busting drug gets new approval: Roche and Genentech’s TNKase (tenecteplase) was approved Monday to treat acute ...